Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs - Hims & Hers Health (NYSE:HIMS), Eli Lilly and Co (NYSE:LLY)
Benzinga·2026-02-12 09:23Novo Nordisk (NYSE:NVO) CEO Mike Doustdar said the company aims to reach about 15 million new patients when Medicare begins covering obesity treatments later this year. However, the CEO said that the Medicare coverage for obesity treatments is unlikely to expand quickly, noting that expecting rapid access would be unrealistic. Doustdar pointed to the slow uptake among commercially insured eligible patients as a sign that adoption will likely take time. He also said that the company is currently negotiating ...